AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $2.575B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| FLT | Ann: Application for quotation of securities - FLT | 04/02/25 | 0 | 1 | |||
|
|||||||
| FLT | Ann: FLT Advance Notice Group Half Year Results | 04/02/25 | 0 | 1 | |||
|
|||||||
| FLT | Ann: Update on ACCC Test Case | 04/04/18 | 0 | 122 | |||
|
|||||||
| FLT | Ann: Appendix 3B | 13:50 | 0 | 54 | |||
|
|||||||
| FLT | Ann: Ceasing to be a substantial holder | 20/03/18 | 0 | 123 | |||
|
|||||||
| FLT | Ann: FLT FY18 Half Year Results Presentation | 17/03/18 | 19 | 4.4K | |||
|
|||||||
| FLT | Ann: Becoming a substantial holder | 07/03/18 | 0 | 94 | |||
|
|||||||
| FLT | Ann: Ceasing to be a substantial holder | 07/03/18 | 0 | 91 | |||
|
|||||||
See All Discussions
ASX News